Restrictions mentioned included a registry of Mifepristone providers and a requirement that providers have admitting privileges at a hospital within one hour of their practices. As commonly practiced today, an abortion provider might have an agreement with a backup doctor for admittance. However, surgical backup at a hospital is rarely, if ever needed with Mifepristone. These and other unnecessary restrictions mentioned would be so limiting that doctors would simply refuse to use it. What women's rights advocates fear is that if something like this were to happen, Mifepristone would be approved but its use rendered null.
Mifepristone is available throughout Europe and China.
Millions of women have used it safely and effectively. In fact, in 1996 the FDA itself ruled that Mifepristone was safe and efficacious. It is outrageous that its use has been denied to women in the United States this long. The lack of availability of Mifepristone in the US is hampering research on the treatment of very serious illnesses. Send a postcard to the United States Food and Drug Administration and the National Institutes of Health.